🇺🇸 Mometasone furoate NS in United States
1 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 1
Most-reported reactions
- Headache — 1 report (100%)
Frequently asked questions
Is Mometasone furoate NS approved in United States?
Mometasone furoate NS does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Mometasone furoate NS in United States?
Glenmark Specialty S.A. is the originator. The local marketing authorisation holder may differ — check the official source linked above.